Latest filing published 20 Nov 2014 for Concert Pharmaceuticals, INC., €2.3M.
Insider track record
No signal scores available.
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -21.0%Entry US$77.20 · Close at T+365 US$61.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Three Arch Management III LLC: trading record in brief
Filings by Three Arch Management III LLC span 3 companies, the busiest being Talphera, Inc., Concert Pharmaceuticals, Inc. and Molecular Templates, Inc. Between 3 March 2006 and 18 November 2014, the trades on record add up to 23 filings.
The open-market side counts 4 purchases for €5.8M alongside 3 sales for €14.5M. The net balance comes to €8.7M on the selling side. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Since January 2014: 2 purchases and 2 sales on the market.
A typical purchase (the median) is worth €621k.
The record was last updated on 20 November 2014 with an open-market sale (€2.3M) in Concert Pharmaceuticals, Inc. The last insider purchase was made public on 21 February 2014, 4,644 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Three Arch Management III LLC
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 237,245 shares@ US$12.29Common StockSEC:0001181431-14-036962:0
- 12,755 shares@ US$12.29Common StockSEC:0001181431-14-036962:1
- 13,545 sharesCommon StockSEC:0001209191-14-012993:0
- 18,060 sharesCommon StockSEC:0001209191-14-012993:1
- 3,612 sharesCommon StockSEC:0001209191-14-012993:2
- 251,941 sharesCommon StockSEC:0001209191-14-012993:3
- 335,922 sharesCommon StockSEC:0001209191-14-012993:4
- 67,184 sharesCommon StockSEC:0001209191-14-012993:5
- 5,281 shares@ US$14.00Common StockSEC:0001209191-14-012993:6Canonical exit: 20 May 2014 (T+90)
- 98,219 shares@ US$14.00Common StockSEC:0001209191-14-012993:7Canonical exit: 20 May 2014 (T+90)
- 31,357 sharesCommon StockSEC:0001181431-11-011588:0
- 583,255 sharesCommon StockSEC:0001181431-11-011588:1
- 25,106 sharesCommon StockSEC:0001181431-11-011588:2
- 466,990 sharesCommon StockSEC:0001181431-11-011588:3
- 44,702 sharesCommon StockSEC:0001181431-11-011588:4
- 831,466 sharesCommon StockSEC:0001181431-11-011588:5
- 27,142 sharesCommon StockSEC:0001181431-11-011588:6
- 65,806 shares@ US$5.00Common StockSEC:0001181431-11-011588:10Canonical exit: 17 May 2011 (T+90)
- 1,223,983 shares@ US$5.00Common StockSEC:0001181431-11-011588:11Canonical exit: 17 May 2011 (T+90)
- 504,860 sharesCommon StockSEC:0001181431-11-011588:7
- 1,430 sharesCommon StockSEC:0001181431-11-011588:8
- 26,615 sharesCommon StockSEC:0001181431-11-011588:9
- 1,000,000 shares@ US$14.50Common StockSEC:0001104659-06-014680:0
23 of 23 declarations